Transcriptome profiling revealed multiple genes and ECM-receptor interaction pathways that may be associated with breast cancer

BackgroundExploration of the genes with abnormal expression during the development of breast cancer is essential to provide a deeper understanding of the mechanisms involved. Transcriptome sequencing and bioinformatics analysis of invasive ductal carcinoma and paracancerous tissues from the same patient were performed to identify the key genes and signaling pathways related to breast cancer development.MethodsSamples of breast tumor tissue and paracancerous breast tissue were obtained from 6 patients. Sequencing used the Illumina HiSeq platform. All. Only perfectly matched clean reads were mapped to the reference genome database, further analyzed and annotated based on the reference genome information. Differentially expressed genes (DEGs) were identified using the DESeq R package (1.10.1) and DEGSeq R package (1.12.0). Using KOBAS software to execute the KEGG bioinformatics analyses, enriched signaling pathways of DEGs involved in the occurrence of breast cancer were determined. Subsequently, quantitative real time PCR was used to verify the accuracy of the expression profile of key DEGs from the RNA-seq result and to explore the expression patterns of novel cancer-related genes on 8 different clinical individuals.ResultsThe transcriptomic sequencing results showed 937 DEGs, including 487 upregulated and 450 downregulated genes in the breast cancer specimens. Further quantitative gene expression analysis was performed and captured 252 DEGs (201 downregulated and 51 upregulated) that showed the same differential expression pattern in all libraries. Finally, 6 upregulated DEGs (CST2, DRP2, CLEC5A, SCD, KIAA1211, DTL) and 6 downregulated DEGs (STAC2, BTNL9, CA4, CD300LG, GPIHBP1 and PIGR), were confirmed in a quantitative real time PCR comparison of breast cancer and paracancerous breast tissues from 8 clinical specimens. KEGG analysis revealed various pathway changes, including 20 upregulated and 21 downregulated gene enrichment pathways. The extracellular matrix–receptor (ECM-receptor) interaction pathway was the most enriched pathway: all genes in this pathway were DEGs, including the THBS family, collagen and fibronectin. These DEGs and the ECM-receptor interaction pathway may perform important roles in breast cancer.ConclusionSeveral potential breast cancer-related genes and pathways were captured, including 7 novel upregulated genes and 76 novel downregulated genes that were not found in other studies. These genes are related to cell proliferation, movement and adhesion. They may be important for research into breast cancer mechanisms, particularly CST2 and CA4. A key signaling pathway, the ECM-receptor interaction signal pathway, was also identified as possibly involved in the development of breast cancer.

[1]  N. Cairns,et al.  Expression of the dihydropyrimidinase related protein 2 (DRP-2) in Down syndrome and Alzheimer's disease brain is downregulated at the mRNA and dysregulated at the protein level. , 1999, Journal of neural transmission. Supplementum.

[2]  Y. Tsukamoto,et al.  Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells. , 2010, Cancer letters.

[3]  S. Seal,et al.  Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. , 1994, Science.

[4]  Charushila Y. Kadam,et al.  Serum levels of soluble Fas ligand, granzyme B and cytochrome c during adjuvant chemotherapy of breast cancer. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[5]  R. Salunga,et al.  Gene expression profiles of human breast cancer progression , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. V. van Diest,et al.  Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene. , 2003, Neoplasia.

[7]  H. Moses,et al.  Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk , 2012, Breast Cancer Research.

[8]  J. Foekens,et al.  Urokinase receptor splice variant uPAR-del4/5-associated gene expression in breast cancer: identification of rab31 as an independent prognostic factor , 2008, Breast Cancer Research and Treatment.

[9]  M. Kerin,et al.  miR-379 Regulates Cyclin B1 Expression and Is Decreased in Breast Cancer , 2013, PloS one.

[10]  Theresa A. Koleck,et al.  An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors. , 2017, Breast cancer.

[11]  M. Capecchi,et al.  ASPM regulates symmetric stem cell division by tuning Cyclin E ubiquitination , 2015, Nature Communications.

[12]  ShaoChuang Wang,et al.  PKMYT1 promoted the growth and motility of hepatocellular carcinoma cells by activating beta‐catenin/TCF signaling , 2017, Experimental cell research.

[13]  Y Taya,et al.  The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. , 2000, Genes & development.

[14]  H. Fu,et al.  Silencing of NUF2 inhibits proliferation of human osteosarcoma Saos-2 cells. , 2016, European review for medical and pharmacological sciences.

[15]  Jose M Arencibia,et al.  Gene expression profiling reveals overexpression of TSPAN13 in prostate cancer. , 2009, International journal of oncology.

[16]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[17]  A. Sayad,et al.  Targeting of BUB1b Gene Expression in Sentinel Lymph Node Biopsies of Invasive Breast Cancer in Iranian Female Patients. , 2016, Asian Pacific journal of cancer prevention : APJCP.

[18]  M. Hashemi,et al.  The Study of “Dihydropyrimidinase Related Proteins (DRPs)” Expression Changes Influence in Malignant Astrocytoma Brain Tumor , 2014, Iranian journal of cancer prevention.

[19]  E. Schuchman,et al.  Identification of Cystatin SA as a Novel Inhibitor of Acid Ceramidase* , 2011, The Journal of Biological Chemistry.

[20]  Illinois.,et al.  Cancer Genetics , 1976, British Journal of Cancer.

[21]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Validation of UBE2C protein as a prognostic marker in node-positive breast cancer , 2009, British Journal of Cancer.

[23]  Emmanuel Barillot,et al.  TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer , 2013, PloS one.

[24]  J. Mao,et al.  Elevated expression of UBE2T exhibits oncogenic properties in human prostate cancer , 2015, Oncotarget.

[25]  Identification of stromal ColXα1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer , 2016, BMC Cancer.

[26]  Xiao-Jun Ma,et al.  Gene expression profiling of the tumor microenvironment during breast cancer progression , 2009, Breast Cancer Research.

[27]  David J. Chen,et al.  Ataxia Telangiectasia Mutated (ATM) Is Essential for DNA-PKcs Phosphorylations at the Thr-2609 Cluster upon DNA Double Strand Break* , 2007, Journal of Biological Chemistry.

[28]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[29]  F. Grizzi,et al.  Pituitary Tumor-Transforming Gene 1 Is Expressed in Primary Ductal Breast Carcinoma, Lymph Node Infiltration, and Distant Metastases , 2013, Disease markers.

[30]  T. Bathen,et al.  Integrative metabolic and transcriptomic profiling of prostate cancer tissue containing reactive stroma , 2018, Scientific Reports.

[31]  B. Ponder.  Cancer genetics , 2001, Nature.

[32]  Ming-ming Nie,et al.  TSPAN1 functions as an oncogene in gastric cancer and is downregulated by miR‐573 , 2015, FEBS letters.

[33]  Jeyakumar Natarajan,et al.  miRNA-mRNA network detects hub mRNAs and cancer specific miRNAs in lung cancer , 2012, Silico Biol..

[34]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[35]  F. Markowetz,et al.  The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.

[36]  D. Olive,et al.  New Insights Into the Regulation of γδ T Cells by BTN3A and Other BTN/BTNL in Tumor Immunity , 2018, Front. Immunol..

[37]  Jeffrey W. Clark,et al.  Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases , 2016, Science Translational Medicine.

[38]  Yunbao Pan,et al.  Increased Jab1/COPS5 is associated with therapeutic response and adverse outcome in lung cancer and breast cancer patients , 2017, Oncotarget.

[39]  Thomas D. Wu,et al.  Expression of protein elongation factor eEF1A2 predicts favorable outcome in breast cancer , 2007, Breast Cancer Research and Treatment.

[40]  Tom Walsh,et al.  Ten genes for inherited breast cancer. , 2007, Cancer cell.

[41]  L. Öhman,et al.  Altered expression of Butyrophilin (BTN) and BTN‐like (BTNL) genes in intestinal inflammation and colon cancer , 2016, Immunity, inflammation and disease.

[42]  Matija Snuderl,et al.  Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis. , 2018, Biomaterials.

[43]  M. Dürst,et al.  Tetraspanin 1 promotes invasiveness of cervical cancer cells. , 2013, International journal of oncology.

[44]  David Spiegel,et al.  Depression and cancer: mechanisms and disease progression , 2003, Biological Psychiatry.

[45]  Leida Zhang,et al.  Downregulation of NUF2 inhibits tumor growth and induces apoptosis by regulating lncRNA AF339813. , 2015, International journal of clinical and experimental pathology.

[46]  Yumin Li,et al.  UBE2T knockdown inhibits gastric cancer progression , 2017, Oncotarget.

[47]  P. Rudan,et al.  TP53 gene polymorphisms and breast cancer in Croatian women: a pilot study. , 2010, European journal of gynaecological oncology.

[48]  Jing-Yuan Fang,et al.  The MAPK signalling pathways and colorectal cancer. , 2005, The Lancet. Oncology.

[49]  Wei Zhang,et al.  Genome-scale analysis identifies GJB2 and ERO1LB as prognosis markers in patients with pancreatic cancer , 2017, Oncotarget.

[50]  Yingchun He,et al.  In silico analyses for potential key genes associated with gastric cancer , 2018, PeerJ.

[51]  Yusuke Nakamura,et al.  Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells. , 2009, Cancer research.

[52]  Bo Song,et al.  Reduction of Orc6 Expression Sensitizes Human Colon Cancer Cells to 5-Fluorouracil and Cisplatin , 2008, PloS one.

[53]  S. Alahari,et al.  Nischarin regulates focal adhesion and Invadopodia formation in breast cancer cells , 2018, Molecular Cancer.

[54]  Wei Zhang,et al.  Tetraspanin 1 is involved in survival, proliferation and carcinogenesis of pancreatic cancer. , 2015, Oncology reports.

[55]  N. Kuemmerle,et al.  Fatty Acids and Breast Cancer: Make Them on Site or Have Them Delivered , 2016, Journal of cellular physiology.

[56]  D. Sgroi,et al.  BACH1, a Novel Helicase-like Protein, Interacts Directly with BRCA1 and Contributes to Its DNA Repair Function , 2001, Cell.

[57]  M. Uhlén,et al.  Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer , 2014, Journal of Ovarian Research.

[58]  W. El-Rifai,et al.  Activin a signaling regulates cell invasion and proliferation in esophageal adenocarcinoma , 2015, Oncotarget.

[59]  Lori Shepherd,et al.  Identification of metastasis-associated breast cancer genes using a high-resolution whole genome profiling approach , 2011, Journal of Cancer Research and Clinical Oncology.

[60]  M. King,et al.  BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. , 2001, Human molecular genetics.

[61]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[62]  T. Hansen,et al.  Reduced CD300LG mRNA tissue expression, increased intramyocellular lipid content and impaired glucose metabolism in healthy male carriers of Arg82Cys in CD300LG: a novel genometabolic cross-link between CD300LG and common metabolic phenotypes , 2015, BMJ Open Diabetes Research and Care.

[63]  S. Ethier,et al.  Transforming potential of alternatively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells. , 2004, Molecular cancer research : MCR.

[64]  N. Rawlings,et al.  Evolution of proteins of the cystatin superfamily , 2005, Journal of Molecular Evolution.

[65]  Christian Pilarsky,et al.  Molecular Profiling of Laser-Microdissected Matched Tumor and Normal Breast Tissue Identifies Karyopherin α2 as a Potential Novel Prognostic Marker in Breast Cancer , 2006, Clinical Cancer Research.

[66]  M. Faghani,et al.  TP53 PIN3 polymorphism associated with breast cancer risk in Iranian women. , 2011, Indian journal of cancer.

[67]  Jun Yu,et al.  Carbonic anhydrase IV inhibits colon cancer development by inhibiting the Wnt signalling pathway through targeting the WTAP–WT1–TBL1 axis , 2015, Gut.

[68]  M. Hemler,et al.  Specific tetraspanin functions , 2001, The Journal of cell biology.

[69]  P. Bjorkman,et al.  The structure and dynamics of secretory component and its interactions with polymeric immunoglobulins , 2016, eLife.

[70]  Zhong Wang,et al.  Next-generation transcriptome assembly , 2011, Nature Reviews Genetics.

[71]  S. Alahari,et al.  Breast Cancer Tumor Suppressors: A Special Emphasis on Novel Protein Nischarin. , 2015, Cancer research.

[72]  B. Drasar,et al.  Environmental Factors and Cancer of the Colon and Breast , 1973, British Journal of Cancer.

[73]  Enrique Lerma,et al.  ASPN and GJB2 Are Implicated in the Mechanisms of Invasion of Ductal Breast Carcinomas , 2012, Journal of Cancer.

[74]  O. Dekkers,et al.  Increased Risk of Breast Cancer at a Young Age in Women with Fibrous Dysplasia , 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[75]  Bruce A.J. Ponder,et al.  Cancer genetics , 2001, Nature.

[76]  M. Weitzman,et al.  Adenovirus oncoproteins inactivate the Mre11–Rad50–NBS1 DNA repair complex , 2002, Nature.

[77]  A. Whittemore,et al.  Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: findings from the Breast Cancer Family Registry. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[78]  A. Ferrando,et al.  A conserved tetraspanin subfamily promotes Notch signaling in Caenorhabditis elegans and in human cells , 2010, Proceedings of the National Academy of Sciences.

[79]  S. Alahari.  Nischarin inhibits Rac induced migration and invasion of epithelial cells by affecting signaling cascades involving PAK. , 2003, Experimental cell research.